| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sellas Life Sciences Group, Inc. (SLS) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 4 sells. SLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 687.0K | $8.92M | - | |
| VP | 557.8K | $7.25M | - | |
| CFO | 554.3K | $7.20M | - | |
| Dir | 154.4K | $2.01M | - | |
| Dir | 92.9K | $1.21M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | Stergiou Angelos M. | President And CEO | Sell | 23,277 | $1.25 | $29,189.36 | -5.2% | |
| Jun 20, 2017 | Nisi Rudolph | Director | Sell | 500 | $0.55 | $273.05 | -3.3% | |
| Feb 8, 2017 | Hudson Bay Capital Management LP | 10% Owner | Sell | 2,363,441 | $0.84 | $1,985,290.44 | -53.7% | |
| Jun 1, 2016 | Dunlap Ryan | Former Chief Financial Officer | Sale+OE | 126,875 | $2.18 | $276,587.50 | -87.2% |